Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug

Plus, news about Abilita Therapeutics, Orion, Novartis, XGEN Venture, Palleon, Henlius, TigaTx, HERVolution Therapeutics and Krystal Biotech:

Gilead now owns 30% of Assembly Biosciences: The …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

AI Tool Boosts Diagnosis Accuracy of Ear Infections in Children, Study Finds

Researchers developed and validated an automated classifier for diagnosing acute otitis media (AOM) in children.

March 6, 2024

Bird flu snapshot: Upstart manufacturers in low- and middle-income countries to start early vaccine work

Bird flu snapshot: This is the latest installment in a series of regular updates on the H5N1 flu outbreak in dairy cows that STAT is

July 29, 2024

Trade groups urge CMS to expand, quickly finalize breakthrough device pathway

Dive Brief: Medtech trade groups have voiced support for the Centers for Medicare and Medicaid Services’ plan to accelerate reimbursement of certain breakthrough devices. In

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.